1887

Chapter 12 : Prevention of Laboratory-Acquired Infections

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Ebook: Choose a downloadable PDF or ePub file. Chapter is a downloadable PDF file. File must be downloaded within 48 hours of purchase

Buy this Chapter
Digital (?) $30.00

Preview this chapter:
Zoom in
Zoomout

Prevention of Laboratory-Acquired Infections, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555817381/9781555817381.ch12-1.gif /docserver/preview/fulltext/10.1128/9781555817381/9781555817381.ch12-2.gif

Abstract:

Laboratory workers are at risk of acquiring infections while at work. This chapter describes the history and epidemiology (including behavioral characteristics) of laboratory-acquired infections and describes the programs, procedures, provisions and practices, and requirements (including risk management) in place to help reduce their frequency and consequence.

Citation: Noble M. 2015. Prevention of Laboratory-Acquired Infections, p 169-182. In Jorgensen J, Pfaller M, Carroll K, Funke G, Landry M, Richter S, Warnock D (ed), Manual of Clinical Microbiology, Eleventh Edition. ASM Press, Washington, DC. doi: 10.1128/9781555817381.ch12
Highlighted Text: Show | Hide
Loading full text...

Full text loading...

References

/content/book/10.1128/9781555817381.mcm11.ch12
1. Herwaldt BL. 2001. Laboratory-acquired parasitic infections from accidental exposures. Clin Microbiol Rev 14:659688.
2. Dale JC,, Pruett SK,, Maker MD. 1998. Accidental needlesticks in the phlebotomy service of the Department of Laboratory Medicine and Pathology at Mayo Clinic Rochester. Mayo Clin Proc 73:611615.
3. Collins CH,, Kennedy DA. 1999. Laboratory Acquired Infections, 4th ed. Butterworth-Heinemann, Oxford, United Kingdom.
4. Birt C,, Lamb C. 1899. Mediterranean or Malta fever. Lancet i:701710.
5. Sewell DL. 2006. Laboratory-acquired infections: are microbiologists at risk? Clin Microbiol Newsl 28:16.
6. Sewell D. 1995. Laboratory-associated infections and biosafety. Clin Microbiol Rev 8:389405.
7. Baron EJ,, Miller JM. 2008. Bacterial and fungal infections among diagnostic laboratory workers: evaluating the risks. Diagn Microbiol Infect Dis 60:241246.
8. Sejvar JJ,, Johnson D,, Popovic T,, Miller JM,, Downes F,, Somsel P,, Weyant R,, Stephens DS,, Perkins BA,, Rosenstein NE. 2005. Assessing the risk of laboratory-acquired meningococcal disease. J Clin Microbiol 43:48114814.
9. The Joint Commission. 2012. Improving Patient and Worker Safety: Opportunities for Synergy, Collaboration and Innovation. The Joint Commission, Oakbrook Terrace, IL.
10. Herwaldt BL,, Juranek DD. 1993. Laboratory-acquired malaria, leishmaniasis, trypanosomiasis, and toxoplasmosis. Am J Trop Med Hyg 48:313323.
11. Noble MA. 2008. Convergence of laboratory quality, safety, and risk. Lab Focus 12:130.
12. International Organization for Standarization. 2012. Medical Laboratories—Requirements for Quality and Competence. ISO 15189:2012. International Organization for Standarization, Geneva, Switzerland.
13. International Organization for Standarization. 2003. Medical Laboratories: Requirements for Safety. ISO 15190:2003. International Organization for Standardization, Geneva, Switzerland.
14. International Organization for Standarization. 2006. Point-of-Care Testing (POCT)—Requirements for Quality and Competence. ISO 22870:2006. International Organization for Standardization, Geneva, Switzerland.
15. International Organization for Standarization. 2008. Medical Laboratories—Reduction of Error through Risk Management and Continual Improvement. ISO/TS 22367:2008. International Organization for Standardization, Geneva, Switzerland.
16. International Organization for Standarization. 2009. Risk Management—Vocabulary. ISO Guide 73:2009. International Organization for Standardization, Geneva, Switzerland.
17. Phillips GB,. 1986. Human factors in microbiological laboratory accidents, p 4348. In Miller BM (ed), Laboratory Safety: Principles and Practices. American Society for Microbiology, Washington, DC.
18. Reason J. 1990. Human Error. Cambridge University Press, New York, NY.
19. Listyowardojo TA,, Nap RE,, Johnson A. 2011. Variations in hospital worker perceptions of safety culture. Int J Qual Health Care 24:915.
20. Anonymous. 1968. Medical laboratory manpower recommendations. Public Health Rep 83:518.
21. Landro L. 13 March 2009. Staff shortages in labs may put patients at risk. Wall Street J. http://online.wsj.com/news/articles/SB124217357954413095.
22. Evans MR,, Henderson DK,, Bennett JE. 1990. Potential for laboratory exposures to biohazardous agents found in blood. Am J Public Health 80:423427.
23. Ashdown LR. 1992. Melioidosis and safety in the clinical laboratory. J Hosp Infect 21:301306.
24. Logan-Henfrey L. 2000. Mitigation of bioterrorist threats in the 21st century. Ann N Y Acad Sci 916:121133.
25. Richmond JY,, Nesby-O’Dell SL. 2002. Laboratory security and emergency response guidance for laboratories working with select agents. MMWR Recommend Rep 51:16.
26. Robinson-Dunn B. 2002. The microbiology laboratory’s role in response to bioterrorism. Arch Pathol Lab Med 126:291294.
27. Kahn LH. 2004. Biodefense research: can secrecy and safety coexist? Biosecur Bioterror 2:8185.
28. Simhon A,, Rahav G,, Shapiro M,, Block C. 2001. Skin disease presenting as an outbreak of pseudobacteremia in a laboratory worker. J Clin Microbiol 39:392393.
29. Thomson RBJr,, Vanzo SJ,, Henry NK,, Guenther KL,, Washington JAII. 1984. Contamination of cultures processed with the isolator lysis-centrifugation blood culture tube. J Clin Microbiol 19:9799.
30. Chosewood LC,, Wilson DE (ed). 2009. Biosafety in Microbiological and Biomedical Laboratories. U.S. Department of Health and Human Services, Washington, DC. http://www.cdc.gov/biosafety/publications/bmbl5/. Accessed 24 September 2013.
31. CSA. 2004. Fume Hoods and Associated Exhaust Systems, vol Z316.5. Canadian Standards Association, Toronto, Canada.
32. Kimman TG,, Smit E,, Klein MR. 2008. Evidence-based biosafety: a review of the principles and effectiveness of microbiological containment measures. Clin Microbiol Rev 21:403425.
33. Sawyer J,, Bennett A,, Haines V,, Elton E,, Crago K,, Speight S. 2007. The effect of microbiological containment systems on dexterity. J Occup Environ Hyg 4:166173.
34. Miller JM,, Astles R,, Baszler T,, Chapin K,, Carey R,, Garcia L,, Gray L,, Larone D,, Pentella M,, Pollock A,, Shapiro DS,, Weirich E,, Wiedbrauk D. 2012. Guidelines for safe work practices in human and animal medical diagnostic laboratories. Recommendations of a CDC-convened, biosafety blue ribbon panel. MMWR Surveill Summ 61(Suppl):1102.
35. Hall CV. 1975. A biological safety centrifuge. Health Lab Sci 12:104106.
36. Chang CL,, Kim HH,, Son HC,, Park SS,, Lee MK,, Park SK,, Park WW,, Jeon CH. 2001. False-positive growth of Mycobacterium tuberculosis attributable to laboratory contamination confirmed by restriction fragment length polymorphism analysis. Int J Tuberc Lung Dis 5:861867.
37. Fiori PL,, Mastrandrea S,, Rappelli P,, Cappuccinelli P. 2000. Brucella abortus infection acquired in microbiology laboratories. J Clin Microbiol 38:20052006.
38. Bennett A,, Parks S. 2006. Microbial aerosol generation during laboratory accidents and subsequent risk assessment. J Appl Microbiol 100:658663.
39. Hambleton P,, Dedonato G. 1992. Protecting researchers from instrument biohazards. Biotechniques 13:450453.
40. Balbo A,, Zhao H,, Brown PH,, Schuck P. 2009. Assembly, loading, and alignment of an analytical ultracentrifuge sample cell. J Vis Exp 5:pii=1530.
41. Ansa VO,, Udoma EJ,, Umoh MS,, Anah MU. 2002. Occupational risk of infection by human immunodeficiency and hepatitis B viruses among health workers in south-eastern Nigeria. East Afr Med J 79:254256.
42. National Sanitation Foundation. 2009. Biosafety Cabinetry: Design, Construction, Performance, and Field Certification. NSF/ANSI 49:2009. National Sanitation Foundation, Ann Arbor,MI. http://standards.nsf.org/apps/group_public/download.php/5457/49i37r1%20Annex%20E%20version%201.pdf.
43. Sewell DL (ed). 2005. Protection of Laboratory Workers from Occupationally Acquired Infections; Approved Guideline, 3rd ed. Clinical and Laboratory Standards Institute, Wayne, PA.
44. Canadian Standards Association. 2002. Evaluation of Single-Use Medical Sharps Containers for Biohazardous and Cytotoxic Waste, vol Z316.602. Canadian Standards Association, Missisauga, Ontario, Canada.
45. ASTM International. 2001. Standard Specification for Puncture Resistance of Materials Used in Containers for Discarded Medical Needles and Other Sharps. F2132-07. ASTM International,West Conshohocken, PA. (Reapproved 2008.)
46. Canadian Standards Association. 2007. Evaluation of Single-Use and Reusable Medical Sharps Containers for Biohazardous and Cytotoxic Waste. Z316.6-07 (R2012). Canadian Standards Association, Missisauga, Ontario, Canada. (Reapproved 2012.)
47. Tan R,, Noble MA. 1993. Sharps utilization and disposal in British Columbia physicians’ offices. Can J Public Health 84:3134.
48. Mecklem RL,, Neumann CM. 2003. Defining and managing biohazardous waste in U.S. research-oriented universities: a survey of environmental health and safety professionals. J Environ Health 66:1722.
49. Tonuci LRS,, Paschoalatto CF,, Pisani R,Jr. 2007. Microwave inactivation of Escherichia coli in healthcare waste. Waste Manag 28:840848.
50. Chitnis V,, Chitnis S,, Patil S,, Chitnis D. 2003. Solar disinfection of infectious biomedical waste: a new approach for developing countries. Lancet 362:12851286.
51. Gautam V,, Thapar R,, Sharma M. 2010. Biomedical waste management: incineration vs. environmental safety. Indian J Med Microbiol 28:191192.
52. Boyce JM,, Pittet D. 2002. Guideline for hand hygiene in health-care settings. Recommendations of the Healthcare Infection Control Practices Advisory Committee and the HIPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. Am J Infect Control 30:S1S46.
53. Sickbert-Bennett EE,, Weber DJ,, Gergen-Teague MF,, Sobsey MD,, Samsa GP,, Rutala WA. 2005. Comparative efficacy of hand hygiene agents in the reduction of bacteria and viruses. Am J Infect Control 33:6777.
54. Gerding DN,, Muto CA,, Owens RCJr. 2008. Measures to control and prevent Clostridium difficile infection. Clin Infect Dis 46(Suppl 1):S43S49.
55. Weber DJ,, Sickbert-Bennett E,, Gergen MF,, Rutala WA. 2003. Efficacy of selected hand hygiene agents used to remove Bacillus atrophaeus (a surrogate of Bacillus anthracis) from contaminated hands. JAMA 289:12741277.
56. Bottone EJ,, Cheng M,, Hymes S. 2004. Ineffectiveness of handwashing with lotion soap to remove nosocomial bacterial pathogens persisting on fingertips: a major link in their intrahospital spread. Infect Control Hosp Epidemiol 25:262264.
57. Messager S,, Hammer KA,, Carson CF,, Riley TV. 2005. Effectiveness of hand-cleansing formulations containing tea tree oil assessed ex vivo on human skin and in vivo with volunteers using European standard EN 1499. J Hosp Infect 59:220228.
58. Kampf G,, Kramer A. 2004. Epidemiologic background of hand hygiene and evaluation of the most important agents for scrubs and rubs. Clin Microbiol Rev 17:863893.
59. Zarpellon MN,, Soares VS,, Albrecht NR,, Bergamasco DR,, Garcia LB,, Cardoso CL. 2008. Comparison of 3 alcohol gels and 70% ethyl alcohol for hand hygiene. Infect Control Hosp Epidemiol 29:960962.
60. Creedon SA. 2005. Healthcare workers’ hand decontamination practices: compliance with recommended guidelines. J Adv Nurs 51:208216.
61. Sawyer J,, Bennett A. 2006. Comparing the level of dexterity offered by latex and nitrile SafeSkin gloves. Ann Occup Hyg 50:289296.
62. Jungbauer FH,, van der Harst JJ,, Groothoff JW,, Coenraads PJ. 2004. Skin protection in nursing work: promoting the use of gloves and hand alcohol. Contact Dermatitis 51:135140.
63. Burke FJ,, Wilson NH,, Cheung SW. 1995. Factors associated with skin irritation of the hands experienced by general dental practitioners. Contact Dermatitis 32:3538.
64. Checchi L,, Gatto MR,, Legnani P,, Pelliccioni GA,, Bisbini P. 1999. Use of gloves and prevalence of glove-related reactions in a sample of general dental practitioners in Italy. Quintessence Int 30:633636.
65. Ramsing DW,, Agner T. 1996. Effect of glove occlusion on human skin. (I). short-term experimental exposure. Contact Dermatitis 34:15.
66. Wrangsjo K,, Wallenhammar LM,, Ortengren U,, Barregard L,, Andreasson H,, Bjorkner B,, Karlsson S,, Meding B. 2001. Protective gloves in Swedish dentistry: use and side-effects. Br J Dermatol 145:3237.
67. Neely AN,, Sittig DF. 2002. Basic microbiologic and infection control information to reduce the potential transmission of pathogens to patients via computer hardware. J Am Med Inform Assoc 9:500508.
68. Piro S,, Sammud M,, Badi S,, Al Ssabi L. 2001. Hospital-acquired malaria transmitted by contaminated gloves. J Hosp Infect 47:156158.
69. Danyluk Q,, Hon CY,, Neudorf M,, Yassi A,, Bryce E,, Janssen B,, Astrakianakis G. 2011. Health care workers and respiratory protection: is the user seal check a surrogate for respirator fit-testing? J Occup Environ Hyg 8:267270.
70. Clapham SJ. 2000. Comparison of N95 disposable filtering facepiece fits using bitrex qualitative and TSI Portacount quantitative fit testing. Int J Occup Environ Health 6:5055.
71. Li Y,, Tokura H,, Guo YP,, Wong AS,, Wong T,, Chung J,, Newton E. 2005. Effects of wearing N95 and surgical facemasks on heart rate, thermal stress and subjective sensations. Int Arch Occup Environ Health 78:501509.
72. Loeb M,, Dafoe N,, Mahony J,, John M,, Sarabia A,, Glavin V,, Webby R,, Smieja M,, Earn DJ,, Chong S,, Webb A,, Walter SD. 2009. Surgical mask vs N95 respirator for preventing influenza among health care workers: a randomized trial. JAMA 302:18651871.
73. Ang B,, Poh BF,, Win MK,, Chow A. 2010. Surgical masks for protection of health care personnel against pandemic novel swine-origin influenza A (H1N1)-2009: results from an observational study. Clin Infect Dis 50:10111014.
74. Centers for Disease Control and Prevention. 2003. Recommended adult immunization schedule—United States, 2003–2004. MMWR Morb Mortal Wkly Rep 52:965969.
75. Kaltsas A,, Sepkowitz K. 2013. Vaccinations for healthcare personnel: update on influenza, hepatitis B, and pertussis. Curr Opin Infect Dis 26:366377.
76. Centers for Disease Control and Prevention. 2002. Laboratory-acquired meningococcal disease—United States, 2000. MMWR Morb Mortal Wkly Rep 51:141144.
77. Boutet R,, Stuart JM,, Kaczmarski EB,, Gray SJ,, Jones DM,, Andrews N. 2001. Risk of laboratory-acquired meningococcal disease. J Hosp Infect 49:282284.
78. Christen G,, Tagan D. 2004. Laboratory-acquired Neisseria meningitidis infection. Med Mal Infect 34:137138. (In French.)
79. Loeb M,, Zando I,, Orvidas MC,, Bialachowski A,, Groves D,, Mahoney J. 2003. Laboratory-acquired vaccinia infection. Can Commun Dis Rep 29:134136.
80. Mempel M,, Isa G,, Klugbauer N,, Meyer H,, Wildi G,, Ring J,, Hofmann F,, Hofmann H. 2003. Laboratory acquired infection with recombinant vaccinia virus containing an immunomodulating construct. J Invest Dermatol 120:356358.
81. Bechtol D,, Carpenter LR,, Mosites E,, Smalley D,, Dunn JR. Brucella melitensis infection following military duty in Iraq. Zoonoses Public Health 58:489–492.
82. Seleem MN,, Boyle SM,, Sriranganathan N. 2010. Brucellosis: a re-emerging zoonosis. Vet Microbiol 140:392398.
83. Chen JD,, Ke CW,, Deng X,, Jiang S,, Liang W,, Ke BX,, Li B,, Tan H,, Liu M. 2013. Brucellosis in Guangdong Province, People’s Republic of China, 2005–2010. Emerg Infect Dis 19:817818.
84. Sayin-Kutlu S,, Kutlu M,, Ergonul O,, Akalin S,, Guven T,, Demiroglu YZ,, Acicbe O,, Akova M,, Occupational Infectious Diseases Study Group. 2012. Laboratory-acquired brucellosis in Turkey. J Hosp Infect 80:326330.
85. Yagupsky P,, Baron EJ. 2005. Laboratory exposures to brucellae and implications for bioterrorism. Emerg Infect Dis 11:11801185.
86. Noviello S,, Gallo R,, Kelly M,, Limberger RJ,, DeAngelis K,, Cain L,, Wallace B,, Dumas N. 2004. Laboratory-acquired brucellosis. Emerg Infect Dis 10:18481850.
87. Robichaud S,, Libman M,, Behr M,, Rubin E. 2004. Prevention of laboratory-acquired brucellosis. Clin Infect Dis 38:e119e122.
88. Carrington M,, Choe U,, Ubillos S,, Stanek D,, Campbell M,, Wansbrough L,, Lee P,, Churchwell G,, Rosas K,, Zaki SR,, Drew C,, Paddock CD,, Deleon-Carnes M,, Guerra M,, Hoffmaster AR,, Tiller RV,, De BK. 2012. Fatal case of brucellosis misdiagnosed in early stages of Brucella suis infection in a 46-year-old patient with Marfan syndrome. J Clin Microbiol 50:21732175.
89. Elsaghir AA,, James EA. 2003. Misidentification of Brucella melitensis as Ochrobactrum anthropi by API 20NE. J Med Microbiol 52:441442.
90. Reddy S,, Manuel R,, Sheridan E,, Sadler G,, Patel S,, Riley P. 2010. Brucellosis in the UK: a risk to laboratory workers? Recommendations for prevention and management of laboratory exposure. J Clin Pathol 63:9092.
91. Yang X,, Skyberg JA,, Cao L,, Clapp B,, Thornburg T,, Pascual DW. 2013. Progress in vaccine development. Front Biol (Beijing) 8:6077.
92. Avashia SB,, Petersen JM,, Lindley CM,, Schriefer ME,, Gage KL,, Cetron M,, DeMarcus TA,, Kim DK,, Buck J,, Montenieri JA,, Lowell JL,, Antolin MF,, Kosoy MY,, Carter LG,, Chu MC,, Hendricks KA,, Dennis DT,, Kool JL. 2004. First reported prairie dog-to-human tularemia transmission, Texas, 2002. Emerg Infect Dis 10:483486.
93. Reintjes R,, Dedushaj I,, Gjini A,, Jorgensen TR,, Cotter B,, Lieftucht A,, D’Ancona F,, Dennis DT,, Kosoy MA,, Mulliqi-Osmani G,, Grunow R,, Kalaveshi A,, Gashi L,, Humolli I. 2002. Tularemia outbreak investigation in Kosovo: case control and environmental studies. Emerg Infect Dis 8:6973.
94. Shapiro DS,, Schwartz DR. 2002. Exposure of laboratory workers to Francisella tularensis despite a bioterrorism procedure. J Clin Microbiol 40:22782281.
95. Feldman KA,, Enscore RE,, Lathrop SL,, Matyas BT,, McGuill M,, Schriefer ME,, Stiles-Enos D,, Dennis DT,, Petersen LR,, Hayes EB. 2001. An outbreak of primary pneumonic tularemia on Martha’s Vineyard. N Engl J Med 345:16011606.
96. Dennis DT,, Inglesby TV,, Henderson DA,, Bartlett JG,, Ascher MS,, Eitzen E,, Fine AD,, Friedlander AM,, Hauer J,, Layton M,, Lillibridge SR,, McDade JE,, Osterholm MT,, O’Toole T,, Parker G,, Perl TM,, Russell PK,, Tonat K. 2001. Tularemia as a biological weapon: medical and public health management. JAMA 285:27632773.
97. Centers for Disease Control and Prevention. 22 March 2011. oa [cfNormal]?>Managing potential laboratory exposures to Francisella tularensis. http://www.cdc.gov/tularemia/laboratoryexposure/. Accessed 8 January 2014.
98. Tiangpitayakorn C,, Songsivilai S,, Piyasangthong N,, Dharakul T. 1997. Speed of detection of Burkholderia pseudomallei in blood cultures and its correlation with the clinical outcome. Am J Trop Med Hyg 57:9699.
99. Dance DA. 2000. Ecology of Burkholderia pseudomallei and the interactions between environmental Burkholderia spp. and human-animal hosts. Acta Trop 74:159168.
100. Corral DM,, Coates AL,, Yau YC,, Tellier R,, Glass M,, Jones SM,, Waters VJ. 2008. Burkholderia pseudomallei infection in a cystic fibrosis patient from the Caribbean: a case report. Can Respir J 15:237239.
101. Centers for Disease Control and Prevention. 2004. Laboratory exposure to Burkholderia pseudomallei—Los Angeles, California, 2003. MMWR Morb Mortal Wkly Rep 53:988990.
102. Sivalingam SP,, Sim SH,, Jasper LC,, Wang D,, Liu Y,, Ooi EE. 2008. Pre- and post-exposure prophylaxis of experimental Burkholderia pseudomallei infection with doxycycline, amoxicillin/clavulanic acid and co-trimoxazole. J Antimicrob Chemother 61:674678.
103. Peacock SJ,, Schweizer HP,, Dance DA,, Smith TL,, Gee JE,, Wuthiekanun V,, DeShazer D,, Steinmetz I,, Tan P,, Currie BJ. 2008. Management of accidental laboratory exposure to Burkholderia pseudomallei and B. mallei. Emerg Infect Dis 14:e2.
104. Singh K. 2009. Laboratory-acquired infections. Clin Infect Dis 49:142147.
105. Collins CH,, Grange JM. 1999. Tuberculosis acquired in laboratories and necropsy rooms. Commun Dis Public Health 2:161167.
106. Nolte KB,, Taylor DG,, Richmond JY. 2002. Biosafety considerations for autopsy. Am J Forensic Med Pathol 23:107122.
107. Moreira TR,, Zandonade E,, Maciel EL. 2010. Risk of tuberculosis infection among community health agents. Rev Saude Publica 44:332338.
108. Centers for Disease Control and Prevention. 2009. Increase in coccidioidomycosis—California, 2000–2007. MMWR Morb Mortal Wkly Rep 58:105109.
109. Sutton DA. 2007. Diagnosis of coccidioidomycosis by culture: safety considerations, traditional methods, and susceptibility testing. Ann N Y Acad Sci 1111:315325.
110. Kohn GJ,, Linne SR,, Smith CM,, Hoeprich PD. 1992. Acquisition of coccidioidomycosis at necropsy by inhalation of coccidioidal endospores. Diagn Microbiol Infect Dis 15:527530.
111. Arsura EL,, Kilgore WB. 2000. Miliary coccidioidomycosis in the immunocompetent. Chest 117:404409.
112. Deus Filho A. 2009. Chapter 2: coccidioidomycosis. J Bras Pneumol 35:920930.
113. Stevens DA,, Clemons KV,, Levine HB,, Pappagianis D,, Baron EJ,, Hamilton JR,, Deresinski SC,, Johnson N. 2009. Expert opinion: what to do when there is Coccidioides exposure in a laboratory. Clin Infect Dis 49:919923.
114. Centers for Disease Control and Prevention. 2008. Laboratory-acquired vaccinia exposures and infections—United States, 2005–2007. MMWR Morb Mortal Wkly Rep 57:401404.
115. Centers for Disease Control and Prevention. 2009. Laboratory-acquired vaccinia virus infection—Virginia, 2008. MMWR Morb Mortal Wkly Rep 58:797800.
116. Britton S,, van den Hurk AF,, Simmons RJ,, Pyke AT,, Northill JA,, McCarthy J,, McCormack J. 2011. Laboratory-acquired dengue virus infection—a case report. PLoS Negl Trop Dis 5:e1324.
117. Jha AK,, Chadha S,, Bhalla P,, Saini S. 2012. Hepatitis B infection in microbiology laboratory workers: prevalence, vaccination, and immunity status. Hepat Res Treat 2012:520362.
118. McCollum AM,, Austin C,, Nawrocki J,, Howland J,, Pryde J,, Vaid A,, Holmes D,, Weil MR,, Li Y,, Wilkins K,, Zhao H,, Smith SK,, Karem K,, Reynolds MG,, Damon IK. 2012. Investigation of the first laboratory-acquired human cowpox virus infection in the United States. J Infect Dis 206:6368.
119. Pedrosa PB,, Cardoso TA. 2011. Viral infections in workers in hospital and research laboratory settings: a comparative review of infection modes and respective biosafety aspects. Int J Infect Dis 15:e366e376.
120. Weigler BJ,, Di Giacomo RF,, Alexander S. 2005. A national survey of laboratory animal workers concerning occupational risks for zoonotic diseases. Comp Med 55:183191.
121. Prejean J,, Song R,, Hernandez A,, Ziebell R,, Green T,, Walker F,, Lin LS,, An Q,, Mermin J,, Lansky A,, Hall HI. 2011. Estimated HIV incidence in the United States, 2006–2009. PLoS One 6:e17502.
122. Alemie GA. 2012. Exploration of healthcare workers’ perceptions on occupational risk of HIV transmission at the University of Gondar Hospital, Northwest Ethiopia. BMC Res Notes 5:704.
123. Gupta A,, Anand S,, Sastry J,, Krisagar A,, Basavaraj A,, Bhat SM,, Gupte N,, Bollinger RC,, Kakrani AL. 2008. High risk for occupational exposure to HIV and utilization of post-exposure prophylaxis in a teaching hospital in Pune, India. BMC Infect Dis 8:142.
124. Lin C,, Li L,, Wu Z,, Wu S,, Jia M. 2008. Occupational exposure to HIV among health care providers: a qualitative study in Yunnan, China. J Int Assoc Physicians AIDS Care (Chic) 7:3541.
125. Do AN,, Ciesielski CA,, Metler RP,, Hammett TA,, Li J,, Fleming PL. 2003. Occupationally acquired human immunodeficiency virus (HIV) infection: national case surveillance data during 20 years of the HIV epidemic in the United States. Infect Control Hosp Epidemiol 24:8696.
126. Centers for Disease Control and Prevention. 2009. Surveillance for Acute Viral Hepatitis—United States, 2007. Centers for Disease Control and Prevention, Atlanta, GA.
127. Bianco A,, Bova F,, Nobile CG,, Pileggi C,, Pavia M. 2013. Healthcare workers and prevention of hepatitis C virus transmission: exploring knowledge, attitudes and evidence-based practices in hemodialysis units in Italy. BMC Infect Dis 13:76.
128. Scoular A,, Watt AD,, Watson M,, Kelly B. 2000. Knowledge and attitudes of hospital staff to occupational exposure to bloodborne viruses. Commun Dis Public Health 3:247249.
129. Centers for Disease Control and Prevention. 2005. Threat to Public Health from Influenza A (H2N2) is Low. Centers for Disease Control and Prevention, Atlanta, GA.
130. Dinh PN,, Long HT,, Tien NTK,, Hien NT,, Mai LTQ,, Phong LH,, Tuan LV,, Tan HV,, Nguyen NB,, Tu PV,, Phuong NTM,, World Health Organization/Global Outbreak Alert and Response Network Avian Influenza Investigation Team in Vietnam. 2006. Risk factors for human infection with avian influenza A H5N1, Vietnam, 2004. Emerg Infect Dis 12:18411847.
131. Gallaher WR. 2009. Towards a sane and rational approach to management of influenza H1N1 2009. Virol J 6:51.
132. Orellana C. 2004. Laboratory-acquired SARS raises worries on biosafety. Lancet Infect Dis 4:64.
133. Barkham TM. 2004. Laboratory safety aspects of SARS at biosafety level 2. Ann Acad Med Singapore 33:252256.
134. Centers for Disease Control and Prevention. 2013. Biosafety recommendations for work with influenza viruses containing a hemagglutinin from the A/goose/Guangdong/1/96 lineage. MMWR Recomm Rep 62:17.
135. Blaser MJ,, Lofgren JP. 1981. Fatal salmonellosis originating in a clinical microbiology laboratory. J Clin Microbiol 13:855858.
136. College of American Pathologists. 13 April 2005.CAP Laboratories Alerted to Destroy an Influenza A Specimen Included in Some Proficiency Testing Kits. College of American Pathologists, Northfield, IL. http://www.cap.org/apps/docs/statements/statement_ptinfluenza.html.
137. Rutala WA,, Weber DJ. 2001. Creutzfeldt-Jakob disease: recommendations for disinfection and sterilization. Clin Infect Dis 32:13481356.
138. Buxton JA,, Henry B,, Crabtree A,, Waheed A,, Coulthart M. 2011. Using qualitative methods to investigate risk perception of Canadian medical laboratory workers in relation to current prion disease infection control policies. J Toxicol Environ Health A 74:241247.
139. Public Health Agency of Canada. 2002. Classic Creutzfeldt-Jakob disease in Canada. An infection control guideline. Health Canada. Can Commun Dis Rep 28(Suppl 5):184.
140. Fichet G,, Comoy E,, Duval C,, Antloga K,, Dehen C,, Charbonnier A,, McDonnell G,, Brown P,, Lasmezas CI,, Deslys JP. 2004. Novel methods for disinfection of prion-contaminated medical devices. Lancet 364:521526.
141. Jackson GS,, McKintosh E,, Flechsig E,, Prodromidou K,, Hirsch P,, Linehan J,, Brandner S,, Clarke AR,, Weissmann C,, Collinge J. 2005. An enzyme-detergent method for effective prion decontamination of surgical steel. J Gen Virol 86:869878.
142. Secker TJ,, Herve R,, Keevil CW. 2011. Adsorption of prion and tissue proteins to surgical stainless steel surfaces and the efficacy of decontamination following dry and wet storage conditions. J Hosp Infect 78:251255.
143. Clinical and Laboratory Standards Institute. 2010. Quality Practices in Noninstrumented Point-of-Care Testing: An Instructional Manual and Resources for Health Care Workers; Approved Guideline POCT08-A, p 120. Clinical and Laboratory Standards Institute, Wayne, PA.
144. PHMSA. 2009. Hazardous Materials: Infectious Substances; Harmonization with the United Nations Recommendations; Final Rule. Pipeline and Hazardous Materials Safety Administration, Washington, DC.
145. Centers for Disease Control and Prevention. 2001. Updated U.S. Public Health Service guidelines for the management of occupational exposures to HBV, HCV, and HIV and recommendations for postexposure prophylaxis. MMWR Recommend Rep 50:1–42.
146. Health Canada. 2004. The Laboratory Biosafety Guidelines, 3rd ed. Public Health Agency of Canada, Ottawa, Canada.

Tables

Generic image for table
TABLE 1

Laboratory safety audits required by ISO 15190:2003

Citation: Noble M. 2015. Prevention of Laboratory-Acquired Infections, p 169-182. In Jorgensen J, Pfaller M, Carroll K, Funke G, Landry M, Richter S, Warnock D (ed), Manual of Clinical Microbiology, Eleventh Edition. ASM Press, Washington, DC. doi: 10.1128/9781555817381.ch12
Generic image for table
TABLE 2

Risk-based classification of microorganisms

Citation: Noble M. 2015. Prevention of Laboratory-Acquired Infections, p 169-182. In Jorgensen J, Pfaller M, Carroll K, Funke G, Landry M, Richter S, Warnock D (ed), Manual of Clinical Microbiology, Eleventh Edition. ASM Press, Washington, DC. doi: 10.1128/9781555817381.ch12
Generic image for table
TABLE 3

Internationally accepted classification of microbial pathogens by risk group

Citation: Noble M. 2015. Prevention of Laboratory-Acquired Infections, p 169-182. In Jorgensen J, Pfaller M, Carroll K, Funke G, Landry M, Richter S, Warnock D (ed), Manual of Clinical Microbiology, Eleventh Edition. ASM Press, Washington, DC. doi: 10.1128/9781555817381.ch12
Generic image for table
TABLE 4

Laboratory design requirements for biosafety level 2 laboratories

Citation: Noble M. 2015. Prevention of Laboratory-Acquired Infections, p 169-182. In Jorgensen J, Pfaller M, Carroll K, Funke G, Landry M, Richter S, Warnock D (ed), Manual of Clinical Microbiology, Eleventh Edition. ASM Press, Washington, DC. doi: 10.1128/9781555817381.ch12
Generic image for table
TABLE 5

Standard microbiology practices for all laboratories of biosafety level 2 and greater

Citation: Noble M. 2015. Prevention of Laboratory-Acquired Infections, p 169-182. In Jorgensen J, Pfaller M, Carroll K, Funke G, Landry M, Richter S, Warnock D (ed), Manual of Clinical Microbiology, Eleventh Edition. ASM Press, Washington, DC. doi: 10.1128/9781555817381.ch12

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error